Review and analysis of over $260 million in defense costs billed by multiple firms for nationwide pharmaceutical injury litigation, including designation as expert and testimony in multiple London arbitrations regarding allocation and reasonableness of defense costs (Pfizer Celebrex Defense Costs Arbitration Matters).
Review and analysis for major dietary supplement producer of over $1,000,000 in attorneys’ fees and expenses billed by law firm for defense of California class action litigation under California Business & Professions Code Sections 17200 and 17500 arising from the manufacture, marketing, distribution and sale of dietary supplement. Served as expert consultant and testified in mediation of fee dispute resulting in settlement for $300,000 less than amount sought by law firm.
Review and analysis of over $140,000,000 in fees, expenses, and litigation costs, including attorneys fees and expenses of over $40,000,000 billed by two law firms, in connection with opposition to petition for attorneys fees and costs in confidential arbitration proceeding between two major pharmaceutical companies concerning dispute over licensure agreement for drug. Appeared at hearing before arbitrator.
Review and allocation for major insurance carrier of over $47 million in attorneys fees and expenses submitted by four law firms in connection with shareholder litigation arising out of acquisition and merger of two major pharmaceutical companies (Warner-Lambert/Pfizer shareholder litigation).
Review and analysis for major health care provider of over $5,000,000 in fees and costs billed by law firm over three year period for defense of numerous medical malpractice cases.
